These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2512204)

  • 1. [Autoimmune myelopathy with particular emphasis on pure red cell aplasia].
    Marmont A
    Haematologica; 1989 Oct; 74(5 Suppl):137-48. PubMed ID: 2512204
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine and pure red cell aplasia.
    Katakkar SB
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):314-6. PubMed ID: 3132775
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythropoiesis disorders and other central autoimmune anemias].
    Casadevall N; Croisille L
    Rev Prat; 2001 Sep; 51(14):1547-51. PubMed ID: 11757270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplasia with erythroid hypoplasia.
    Rawat S; Thakur R
    Am J Hematol; 2006 Jul; 81(7):557-8. PubMed ID: 16755573
    [No Abstract]   [Full Text] [Related]  

  • 5. Pure red cell aplasia: treatment with intravenous immunoglobulin concentrate.
    Ballester OF; Saba HI; Moscinski LC; Nelson R; Foulis P
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):106-8. PubMed ID: 1509289
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of pure red cell aplasia.
    Marmont AM
    Semin Hematol; 1991 Oct; 28(4):285-97. PubMed ID: 1759169
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplastic pure red cell aplasia.
    Xu Z; Mueller R
    Blood; 2021 Aug; 138(6):500. PubMed ID: 34383041
    [No Abstract]   [Full Text] [Related]  

  • 8. Recovery of erythropoiesis following allogeneic bone marrow transplantation for chronic lymphocytic leukaemia-associated pure red cell aplasia.
    de Vetten MP; van Gelder M; de Greef GE
    Bone Marrow Transplant; 2001 Apr; 27(7):771-3. PubMed ID: 11360121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red cell aplasia induced by erythropoiesis-stimulating agents.
    Pollock C; Johnson DW; Hörl WH; Rossert J; Casadevall N; Schellekens H; Delage R; De Francisco A; Macdougall I; Thorpe R; Toffelmire E
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):193-9. PubMed ID: 18178785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythroblastopenia, myelodysplastic syndrome and cytogenetic study].
    Gil García S; Rodríguez García JA
    Sangre (Barc); 1997 Feb; 42(1):85. PubMed ID: 9229810
    [No Abstract]   [Full Text] [Related]  

  • 11. Gamma globulin for antibody-mediated pure red-cell aplasia.
    Etzioni A; Pollack S; Benderly A
    N Engl J Med; 1988 Apr; 318(15):994. PubMed ID: 3127712
    [No Abstract]   [Full Text] [Related]  

  • 12. Pure red cell aplasia associated with thymoma.
    Lahiri TK; Agrawal D; Agrawal K; Shukla J
    Indian J Chest Dis Allied Sci; 2002; 44(4):259-62. PubMed ID: 12437240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythromyelosis in the outcome of partial red cell aplasia].
    Pivnik AV; Idel'son LI; Vorob'ev VG; Grechikhina EN; Evdokimova NM
    Ter Arkh; 1986; 58(9):97-9. PubMed ID: 3097862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
    Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
    Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of pure red-cell aplasia induced by erythropoiesis stimulating agents].
    Rossert J; Casadevall N
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S283-6. PubMed ID: 17373271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythroblastopenia associated with a myelodysplastic syndrome].
    Rodríguez García JA; Gil García S
    Sangre (Barc); 1996 Jun; 41(3):260. PubMed ID: 8966655
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myelodysplastic syndrome accompanied by i(17) (q10) anomaly following pure red cell aplasia and transient myeloproliferative stage].
    Yokohama A; Murata N; Shimano S; Sakuraya M; Tamura J; Karasawa M; Naruse T
    Rinsho Ketsueki; 1999 Jan; 40(1):34-9. PubMed ID: 10067094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo].
    Luraschi A; Montanara S; Fedeli P; Buscaglia P; Fossati O; Cozzi S; Castello A
    Recenti Prog Med; 2008 May; 99(5):255-7. PubMed ID: 18581968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin.
    McGuire WA; Yang HH; Bruno E; Brandt J; Briddell R; Coates TD; Hoffman R
    N Engl J Med; 1987 Oct; 317(16):1004-8. PubMed ID: 3116428
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelodysplastic syndrome with erythroid hypoplasia.
    Goyal R; Varma N; Marwaha RK
    J Clin Pathol; 2005 Mar; 58(3):320-1. PubMed ID: 15735169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.